Amicus Therapeutics to Announce Third Quarter 2025 Financial Results on November 4, 2025
Amicus Therapeutics (Nasdaq: FOLD) will announce third quarter 2025 financial results and host a conference call and live audio webcast on Tuesday, November 4, 2025 at 8:30 a.m. ET.
Phone participants must register online to receive a dial-in number and personal PIN; web participants can register at ir.amicusrx.com (recommended 15 minutes before the call). An archived webcast and slides will be posted on the company website shortly after the live event.
Investor and media contacts are listed for follow-up.
Amicus Therapeutics (Nasdaq: FOLD) annuncerà i risultati finanziari del terzo trimestre 2025 e terrà una conference call e una diretta web audio martedì 4 novembre 2025 alle 8:30 ET.
I partecipanti al telefono devono registrarsi online per ricevere un numero di interno e PIN personale; i partecipanti web possono registrarsi su ir.amicusrx.com (consigliato arrivare 15 minuti prima della chiamata). Una conferenza web archiviata e le diapositive saranno pubblicate sul sito dell'azienda poco dopo l'evento in diretta.
I contatti per investitori e media sono elencati per ulteriori contatti.
Amicus Therapeutics (Nasdaq: FOLD) anunciará los resultados financieros del tercer trimestre de 2025 y organizará una conferencia telefónica y una transmisión en vivo por audio el martes 4 de noviembre de 2025 a las 8:30 a.m. hora del Este (ET).
Los participantes por teléfono deben registrarse en línea para recibir un número de marcación y un PIN personal; los participantes web pueden registrarse en ir.amicusrx.com (se recomienda hacerlo 15 minutos antes de la llamada). Se publicará una grabación de la webcast y las diapositivas en el sitio web de la empresa poco después del evento en vivo.
Los contactos de inversores y medios están disponibles para seguimiento.
Amicus Therapeutics (나스닥: FOLD)는 2025년 3분기 재무 실적을 발표하고 2025년 11월 4일 화요일 오전 8:30(동부 표준시) 컨퍼런스 콜 및 실시간 오디오 웹캐스트를 개최합니다.
전화 참가자는 다이얼인 번호와 개인 PIN을 받기 위해 온라인으로 등록해야 하며, 웹 참가자는 ir.amicusrx.com에서 등록할 수 있습니다(통화 시작 15분 전 권장).
라이브 이벤트 직후 웹캐스트의 아카이브와 슬라이드가 회사 웹사이트에 게시될 예정입니다.
투자자 및 언론 연락처가 후속 조치를 위해 기재되어 있습니다.
Amicus Therapeutics (Nasdaq: FOLD) annoncera les résultats financiers du troisième trimestre 2025 et organisera une conférence téléphonique et une diffusion audio en direct le mardi 4 novembre 2025 à 8 h 30, heure de l’Est (ET).
Les participants téléphoniques doivent s’inscrire en ligne pour recevoir un numéro d’appel et un code PIN personnel; les participants web peuvent s’inscrire sur ir.amicusrx.com (recommandé 15 minutes avant l’appel).
Une archive de la webcast et les diapositives seront publiées sur le site de l’entreprise peu après l’événement en direct.
Les contacts investisseurs et médias sont fournis pour le suivi.
Amicus Therapeutics (Nasdaq: FOLD) wird die Finanzergebnisse des dritten Quartals 2025 bekannt geben und am Dienstag, dem 4. November 2025 um 8:30 Uhr Eastern Time eine Telefonkonferenz sowie einen Live-Audio-Webcast anbieten.
Telefonteilnehmer müssen sich online registrieren, um eine Durchwahlnummer und eine persönliche PIN zu erhalten; Web-Teilnehmer können sich unter ir.amicusrx.com registrieren (empfohlen 15 Minuten vor der Sitzung).
Ein archivierter Webcast und Folien werden kurz nach dem Live-Event auf der Unternehmenswebsite veröffentlicht.
Anleger- und Medienkontakte stehen für Nachverfolgung zur Verfügung.
سيعلن Amicus Therapeutics (ناسداك: FOLD) عن نتائج الربع الثالث من 2025 وسيستضيف مكالمة مؤتمر وبث صوتي مباشر يوم الثلاثاء 4 نوفمبر 2025 الساعة 8:30 صباحاً بتوقيت شرق الولايات المتحدة.
يجب على المشاركين عبر الهاتف التسجيل عبر الإنترنت للحصول على رقم اتصال داخلي ورمز PIN شخصي؛ يمكن للمشاركين عبر الويب التسجيل على ir.amicusrx.com (ينصح بالوصول قبل 15 دقيقة من المكالمة).
سيتم نشر بث مسجل للويب والشرائح على موقع الشركة الإلكتروني فور انتهاء الحدث المباشر.
جهات اتصال المستثمرين ووسائل الإعلام مذكورة للمتابعة.
Amicus Therapeutics（纳斯达克：FOLD） 将公布 2025 年第三季度财务业绩，并于 2025 年 11 月 4 日（星期二）美国东部时间上午 8:30 举行电话会议和现场音频网络广播。
拨打电话的参与者必须在线注册以接收拨入号码和个人 PIN；网页参与者可在 ir.amicusrx.com 注册（建议在呼叫开始前 15 分钟）。现场网络广播的存档和幻灯片将在现场活动结束后不久发布在公司网站上。
投资者和媒体联系信息列出，供后续跟进。
- None.
- None.
PRINCETON, N.J., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that the Company will host a conference call and live audio webcast on Tuesday, November 4, 2025, at 8:30 a.m. ET to discuss financial results for the quarter ended September 30, 2025.
Participants and investors interested in accessing the call by phone will need to register using the online registration form. After registering, all phone participants will receive a dial-in number along with a personal PIN to access the event. A live audio webcast and related presentation materials can also be accessed via the Investors section of the Amicus Therapeutics corporate website at ir.amicusrx.com. Web participants are encouraged to register on the website 15 minutes prior to the start of the call.
An archived webcast and accompanying slides will be available on the Company's website shortly after the conclusion of the live event.
About Amicus Therapeutics
Amicus Therapeutics (Nasdaq: FOLD) is a global, patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare diseases. With extraordinary patient focus, Amicus Therapeutics is committed to advancing and expanding a pipeline of cutting-edge, first- or best-in-class medicines for rare diseases. For more information please visit the company’s website at www.amicusrx.com, and follow on LinkedIn.
CONTACT:
Investors:
Amicus Therapeutics
Andrew Faughnan
Vice President, Investor Relations
afaughnan@amicusrx.com
(609) 662-3809
Media:
Amicus Therapeutics
Brendan McEvoy
Executive Director, External Communications
bmcevoy@amicusrx.com
(609) 662-5005
FOLD–G
FAQ
When will Amicus Therapeutics (FOLD) report Q3 2025 results?
How do I join the Amicus (FOLD) Q3 2025 earnings call by phone?
Where can I listen to the Amicus (FOLD) live audio webcast for Q3 2025?
Will Amicus (FOLD) provide slides or an archived webcast after the Q3 2025 call?
Who should investors contact for questions about Amicus (FOLD) Q3 2025 results?
Will media have a separate contact for Amicus (FOLD) Q3 2025 communications?
